SCHEMBL5685375

SCHEMBL5685375

CCOC(=O)/C=C/c1cc(F)c(OCc2ccccc2)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.55
▸ CA4 P22748 1/20 0.55
▸ CA6 P23280 1/20 0.55
▸ CA5A P35218 1/20 0.55
▸ CA7 P43166 1/20 0.55
▸ CA9 Q16790 1/20 0.55
▸ CA14 Q9ULX7 1/20 0.55
▸ CA5B Q9Y2D0 1/20 0.55
▸ ALOX5 P09917 5/20 0.54
▸ FDPS P14324 1/20 0.53
▸ MAOB P27338 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ APP P05067 3/20 0.50
▸ TTR P02766 2/20 0.50
▸ MET P08581 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ PDE4A P27815 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685380 1.00 CA12 (0.55) CA12CA4CA6CA5ACA7
SCHEMBL6585887 0.92 CA12 (0.61) CA12CA4CA6CA5ACA7
SCHEMBL6585882 0.92 CA12 (0.61) CA12CA4CA6CA5ACA7
SCHEMBL15668975 0.91 LMNA (0.53) CA12CA4CA6CA5ACA7
SCHEMBL15668978 0.91 LMNA (0.53) CA12CA4CA6CA5ACA7
SCHEMBL22555962 0.88 KDM4E (0.57) ALOX5KDM4EALDH1A1APPHTR1A
SCHEMBL14253565 0.87 CA12 (0.55) CA12CA4CA6CA5ACA7
SCHEMBL5685197 0.82 KDM4E (0.67) CA12CA4CA6CA5ACA7
SCHEMBL5685437 0.82 FDPS (0.74) CA12CA4CA6CA5ACA7
SCHEMBL14253551 0.82 LMNA (0.61) CA12CA4CA6CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122064-A1 Amides and method for plant diseases control with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 — — US disclosed
US-20060122065-A1 Amide compound and method of controlling plant disease with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 — — US disclosed
EP-1640360-A1 AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-29 — — EP disclosed
EP-1577290-A1 AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2005-09-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122065-A1 Amide compound and method of controlling plant disease with the same CBR3, C5, CLN6 CA12 1629/4885CA4 1786/4885CA6 859/4885
US-20060122064-A1 Amides and method for plant diseases control with the same ARG1, ARGLU1, ARG2 CA12 2691/4885CA4 3115/4885CA6 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback